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A B S T R A C T
Objective: As the population ages, obliterative procedures (OP) are expected to become an increasingly
important treatment option. The primary aim of this study was to evaluate vaginal and urinary symptoms
3 months after OP and peri- and postoperative complications. The secondary aim was to investigate long-
term outcomes, including patient satisfaction, regret rate and the rate of symptomatic recurrent prolapse
after OP. Another secondary aim was to evaluate the feasibility of performing OP under local anesthesia
(LA) as increasingly more operations are performed under LA.
Study design: Retrospective study of 43 women who underwent OP during a 10-year period. Patients
completed three prolapse questions from the International Consultation on Incontinence-Vaginal
Symptoms (ICIQ-VS) and the International Consultation on Incontinence Questionnaire- Urinary
Incontinence Short Form (ICIQ-UI SF) before undergoing surgery, 3 months postoperatively and at long-
term follow-up. Records were reviewed for complications, use of anesthetics, recurrences, patient
satisfaction and regret.
Results: A Le Fort colpocleisis was performed in 31 (72 %) and a colpectomy in 12 (28 %) patients. At 3
months` follow-up, patients had a statistically significant improvement in vaginal symptoms. Twelve
patients (46 %) became continent, compared with 14 (54 %) with remaining urinary incontinence (UI).
There were no patients with de novo UI 3 months’ after surgery. Total complication rate was 4,6% (2/43). A
symptomatic recurrent prolapse occurred in 4 patients (9.3 %). The satisfaction rate was 86 %. No patients
reported regret choosing to have vaginal closure surgery. Twenty one (49 %) of the procedures were
performed under local anesthesia with intravenous sedation.
Conclusion: Obliterative procedures are good surgical options for elderly women with a positive impact
on vaginal and urinary symptoms, low complication and recurrence rate. Patients report high satisfaction
and no regret over loss of sexual ability at longterm follow-up. OP under LA with intravenous sedation is a
feasible and safe option.
© 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Background
Based on a Danish population- based registry study the lifetime
risk of having pelvic organ prolapse (POP) surgery is 18.7 % for an
80-year-old woman and 21.5 % for women aged 85+ years [1].
The surgical management of POP includes reconstructive and
obliterative procedures (OP). Reconstructive surgery corrects the
prolapsed vagina and aims to restore normal anatomy, while OP
(colpectomy and Le Fort colpocleisis) are defined as operations
obliterating the vagina in elderly women who do not have active
intercourse or a wish for future intercourse.
Obliterative procedures are highly effective surgical treatments
for advanced apical prolapse with success rates between 91 % and
100 % [2] and recurrence rates as low as 4.2 % [3].
Major complication rate is about 4% and is often related to a
concomitant hysterectomy or other concomitant procedures.
Minor complications are inconsistently reported but probably
occur in up to 15 % of women [2].
However, overall patient satisfaction with these OP is greater
than 90 % [4–7].
As the population ages, this procedure is expected to become an
increasingly important treatment option.
Abbreviations: OP, obliterative procedures; ICIQ-VS, International Consultation
on Incontinence-Vaginal Symptoms; ICOQ-UI SF, International Consultation on
Incontinence Questionnaire - Urinary Incontinence Short Form; LA, local
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ymptomatic recurrent prolapse after vaginal OP. Another second-
ry aim was to evaluate the feasibility of performing OP under local
nesthesia (LA) as increasingly more operations are performed
nder LA.
aterial and methods
This prospective follow-up observational study included all
omen who underwent a colpectomy or a Le Fort colpocleisis in
ur department during a 10-year period between January 2008 and
anuary 2018. A total of 43 patients were identified. All medical
ase records and data from the national Danish Urogynecological
atabase [8] were reviewed. All patients completed three modified
rolapse questions from the International Consultation on
ncontinence-Vaginal Symptoms (ICIQ-VS) [9] and the Interna-
ional Consultation on Incontinence – Urinary Incontinence Short
orm (ICIQ-UI SF) [10,11] before surgery and 3 months postopera-
ively. The three modified questions from ICIQ-VS used in our
valuation of symptomatic bulge sensation were: 1: “Do you feel a
ump or bulge come out of your vagina or can you feel a lump in or
utside of your vagina?” (ever (0), occasionally (1), sometimes (2),
ost of the time (3) or all of the time (4)) and 2: “How much does
his bother you?” not at all (0), a little (1), some (2), very much (3)
nd 3: “How much does this affect your daily life?” (0–10). A score
as constructed with 0 in an asymptomatic patient and a score of
7 in a patient with maximum bother. ICIQ-UI-SF was used to
valuate the severity of urinary incontinence and its impact on
ealth-related quality of life. The short form contains three scored
tems and an un-scored self-diagnostic item. A total score for the
hree scored items is calculated by adding them up. A score of 0
ndicates a totally continent patient. Maximum score for worst
ncontinence is 21. The un-scored self-diagnostic item is used to
lassify the type of incontinence: stress, urge, mixed or undefined
ncontinence. Undefined UI is described as “leaks when you have
nished urinating and are dressed” and “leaks for no obvious
easons”. The Danish version of the ICIQ-UI SF has been translated
rom English but has not been validated.
Demographic data included age, body mass index (BMI),
umber of births, previous caesarean sections and previous
rolapse and incontinence operations. Preoperative evaluation
ncluded physical examination including POPQ.
During colpectomy, most of the vaginal epithelium is dissected
ff the underlying fibromuscular layers from within the hymenal
ing posteriorly and to the urethrovesical junction anteriorly, and a
eries of purse-string sutures are placed [12]. Performing LeFort
olpocleisis, rectangular portions of the anterior and posterior
aginal walls are demarcated within the same margins posteriorly
nd anteriorly, and the vaginal epithelium is dissected off the
nderlying fibromuscular layers with a sharp dissection. Multiple
ayers of sutures are placed plicating the posterior to the anterior
bromuscular layer of the vaginal walls, leaving a lateral tunnel on
ach side [12]. Concomitant perineorrhaphy is not a standard
ractice in our department.
The mode of anesthesia was dependent on the patient’s
ondition and preferences.
Postoperative clinical follow-up at three months was per-
ormed for all patients.
In June 2020, all patients who were still alive received the same
uestionnaires in order to collect data for a long-term follow-up. If
choosing vaginal closure surgery for prolapse. No clinical follow-up
was performed.
Statistical analysis
Descriptive statistics were used to describe the study popula-
tion
The Ethics Committee, Region Nordjylland, Denmark approved
the study. The study was registered at The Health Department,
Region Nordjylland (no. 2019142).
Results
A total of 43 patients underwent an obliterative procedure
during the study period. A Le Fort colpocleisis was performed in 31
(72 %) and a colpectomy in 12 (28 %) patients. One patient (2,3%)
underwent concomitant perineorrhaphy. No other concomitant
procedures were performed.
Demographic data of the study population are shown in Table 1.
All patients attended a 3 months follow-up. At 3 months`
follow-up, patients had a statistically significant improvement in
vaginal symptoms with a preoperative mean ICIQ-VS score of 13.3
declining to 0.72.
Postoperative changes in urinary incontinence are shown in
Fig. 1. There were no patients with de novo UI 3 months’ after
surgery. A total of 13 patients (93 %) who remained incontinent
after prolapse surgery according to the ICIQ-UI SF showed
improvement in UI and in only one patient urinary incontinence
symptoms deteriorated. Mean ISIQ-UI-SF score before surgery was
10,7, which declined to 2,7 postoperatively.
Twenty one (49 %) of the procedures were performed under
local anesthesia with intravenous sedation,12 (28 %) under general
anesthesia and 10 (23 %) under spinal anesthesia.
Of the 43 patients, 25 (58 %) were done as day cases.
Only one patient had a perioperative complication, a 3 mm’s
small bladder perforation. One patient experienced a postopera-
tive complication. She was admitted and reoperated because of a
vaginal hematoma one week after primary surgery. Total peri- and
postoperative complication rate was 4,6% (2/43).
In four patients (9,3%) a symptomatic recurrent prolapse
occurred 3–17 months (median 3 months) after surgery (Table 2).
One patient with a recurrent total uterine prolapse at 3 months
follow-up, stated a 14 days period of severe cough short time after
surgery. She wanted to avoid repeat surgery and was treated
successfully with vaginal pessary. Two other patients experienced
a recurrence in the anterior compartment. When reviewing their
surgery notes, we found that these patients underwent incomplete
closure of the vagina leaving total vaginal lengths of 6 cm. These
two women underwent site-specific anterior wall repair. The
fourth patient experienced a complete breakdown of the
Table 1
Demographics of the study population.
Study population N = 43
Age, median (range), years 82 (6396)
Parity, median 3 (08)
Body mass index, kg/m2: mean (range) 25,1 (17,9034,50)
Cesarean section: n (%) 0 (0%)
Previous hysterectomy: n (%) 12 (27,9%)
Previous prolapse surgery: n (%) 10 (23,2%)
Previous anti-incontinence surgery: n (%) 0 (0%)
Pessary use: n (%) 27 (62,7%)
Prolapse stage
III 14 (33 %)
IV 29 (67 %)he patients didn’t respond to the first letter, a second attempt was
erformed in August 2020. Moreover, patients were questioned
bout whether they felt “cured”, “greatly improved”, “somewhat
mproved”, “not improved”, or “worsened” regarding their surgical
peration. The women were also asked whether they regretted143
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colpocleisis 23 months after the primary surgery.
21 patients had died during long-term follow-up. Mean follow-
up time from surgery to death was 53 months (range 3–124).
22 patients (51 %) of 43 patients were still alive in June 2020 and
received the same questionnaires in order to collect data for a long-
term follow-up. 14 patients completed questionnaires, represent-
ing a 64 % response rate.
Average time since surgery to completed questionnaire was 73
months (range 31–134).
Pre- and postoperative data on the ICIQ-VS score showed
statistically significant improvement in all 14 patients, with
preoperative mean score of 13.4 declining to 0.14 at 3 months
follow-up. At long-term follow-up, the mean prolapse score was
slightly higher with a mean score of 2.2.
Nine of the 14 (64 %) patients were incontinent before surgery.
At 3 months` follow-up, 4 became continent, 4 reported improve-
ment in UI and only one reported deterioration in UI. Mean ICIQ-UI
SF score before surgery among patients who were alive and
answered the questionnaire at long-term follow-up was 8,78,
declining to 4,28 at 3 months` follow-up. At long-term follow-up
the score has slightly increased to 6,14.
Regarding patient satisfaction, 12 patients (86 %) felt “cured”,
“greatly improved” and “somewhat improved”, 2 women felt “not
improved” at long-term follow-up. Both patients, who stated no
improvement at long-term follow-up, had ICIQ-VS scores of 10 and
6 and experienced urge urinary incontinence with ICIQ-UI SF
scores of 9 and 11. No patients reported regret choosing to have
vaginal closure surgery. None of the 14 women reported any
surgery for prolapse or urinary incontinence since their
obliterative surgery. Only one patient reported use of anticholin-
ergic medicine for OAB.
Discussion
In this study, we found an improvement in vaginal and urinary
symptoms and no incidents of de novo UI 3 months OP. Recurrence
rates were low, and patients had no regret over loss of sexual ability
at long-term follow-up. We found a high feasibility of performing
OP under local anesthesia.
Our study results showing a significant improvement in vaginal
symptoms 3 months after the obliterative procedures are
consistent with previous studies [5–7,13–18].
This study found, that 26 (60 %) of 43 patients had concomitant
UI. A total of 46 % of patients with preoperative UI became
completely dry after obliterative procedures alone, and up to 93 %
of women experienced improvement in UI 3 months after surgery.
It is somewhat difficult to compare our data to other studies
because most of studies described OP with concomitant anti-
incontinence procedures. In our opinion, there is no need to
perform a concomitant anti-incontinence procedure and it is
better to await effects of prolapse surgery alone [19].
In contrast to some previous studies [4,5,20], where de novo UI
has been reported in up to 27 % of women undergoing OP, we found
no patients who complained of de novo stress UI 3 months after
surgery. One possible explanation could be our surgical technique.
We remove the anterior vaginal epithelium above the urethro-
vesical junction. Thus, we avoid operation in the area under the
urethra in order not to compromise the nerves and tissue in this
area and in order not to pull the urethra down. This might prevent
the occurrence of de novo SUI postoperatively which is in
agreement with a colpocleisis review by FitzGerald et al. [2].
Some studies have shown data on anti-incontinence surgery at
the time of colpocleisis or colpectomy [4,5,7,13,16,17,20,21].
Winkelman et al. [21] found that women with a concurrent
midurethral sling procedure were more likely to have postopera-
tive urinary symptoms. Zebede et al. [4] demonstrated that major
complications were unrelated to the colpocleisis procedure itself
but were a consequence of concomitant procedures including sling
procedures.
In agreement with other studies [4,13,16,18], we found that OP
are low-risk procedures. There were no serious peri- and
postoperative complications.
A large study performed by Sung et al. [22] showed that elderly
women have a higher risk of mortality and morbidity following
urogynecologic surgery, regardless of comorbidity status. They
found that elderly women 80 years and older who underwent
obliterative procedures had a significant lower risk of complication
compared with patients who underwent reconstructive proce-
dures for pelvic prolapse (17 % vs 247%). Furthermore, our findings
suggest that local anesthesia or regional anesthesia is a feasible
option for OP thus reducing the use of general anesthesia which
can be harmful for the elderly patients. 72 % of our patients
Fig. 1. Changes in urinary incontinence at 3 months follow-up.
Table 2
Characteristics of patients with a recurrent prolapse.
1 2 3 4
Age at the time of OP, years 77 78 85 72
BMI, kg/m2 23,20 19,60 22,00 30,50
Number of births 3 1 5 3
Previous hysterectomy No Yes Yes No
Previous POP surgery No Yes Yes No
Previous UI surgery No No No No
Prolapse stage before OP 3 3 3 4
Time to recurrence 3 months 3 months 3 months 17 months
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edation or regional anesthesia. This information can be useful
or the counseling and information of women who are planning to
ndergo prolapse surgery.
Regarding a concomitant hysterectomy at the time of colpo-
leisis, several studies showed that a concomitant hysterectomy is
ssociated with longer operative times and higher blood loss
15,23,24].
These findings highlight the fact that concomitant procedures
t the time of obliterative surgery carry their own risks and
omplications. In our practice we do not perform concomitant
ysterectomy with obliterative procedures. We strongly support
he opinion that a concomitant hysterectomy should be reserved to
omen with uterine pathology [13,23,25]. That is why, it is
mportant to rule out the possible uterine pathology before surgery
y doing an ultrasound of the uterus and taking an endometrial
iopsy if needed.
At long-term follow-up, no patients expressed regret over loss
f coital ability. This is in accordance with many other studies
13,16,17,22,26]. In contrast, among the 62 women in Von
echmann’s et al. [15] study, regret over loss of coital ability
ccurred in 129% of patients. Among the 8 patients who expressed
egret, there was variability on the degree of regret and the authors
elieve that this is a possible explanation for their higher regret
ate.
Our study revealed that, at long-term follow-up, 86 % of
atients were satisfied with the treatment and no women had
orsening of prolapse symptoms after surgery. Lower rates of
atisfaction of 78 % were found also in a study by Winkelmann
t al. [22]. The authors believed that it could be due to the
elatively high prevalence of postoperative bowel and bladder
ymptoms at long-term follow-up. They highlighted the need to
ounsel patients about the long-term outcomes and importance
o contact doctor not only for recurrence of vaginal symptoms,
ut perhaps more importantly with other bothersome pelvic floor
ymptoms.
According to a review of the literature, a recurrence rate after
P is about 4,2% [3]. The reasons for recurrent prolapse are
ssociated with a faulty surgical technique or primary infection.
he study of Krissi et al. [13] showed that longer postoperative
aginal length and wider genital hiatus were associated with
rolapse recurrence. Symptomatic recurrence, in our study,
ccurred in 4 (9,3%) patients, median 3 months after surgery.
wo patients, who experienced a recurrence, had incomplete
losure of vagina during the primary surgery which could probably
ead to the recurrence of prolapse in the anterior compartment.
one of those patients were treated with concomitant perineor-
haphy.
The strength of our study is that the same questionnaire was
sed both pre- and postoperatively and at long-term follow-up,
iving more exact information about changes in vaginal and UI
ymptoms. All the data were entered into the database when
vents took place. Obliterative surgery is not a commonly
erformed procedure for prolapse in women, which is why it
as not possible to include more patients in this single-center
tudy. Lastly, 36 % of our patients were excluded from our long-
erm follow-up because of their missing respond to the question-
aire. Long-term follow-up in the elderly is always challenging
ainly because of issues with dementia and other medical
omorbidities.
under LA with intravenous sedation is a feasible and safe option.
However, additional studies are required to validate our results.
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